Fact Meets Function

Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function.

This peer-reviewed study demonstrates that adjunctive thymosin beta-4 (TB4) combined with standard antibiotic therapy (ciprofloxacin) not only reduces bacterial keratitis severity and accelerates wound healing, but critically also promotes corneal nerve regeneration and restores visual function—outcomes that represent significant clinical advantages beyond infection control alone. The research fills a previously unexplored gap by quantifying TB4’s impact on two often-neglected but essential determinants of long-term patient outcomes: sensory nerve recovery and functional vision restoration. For practitioners, this represents compelling evidence that TB4 adjunctive therapy addresses the full spectrum of corneal infection recovery, not just pathogen elimination.

Reparative Outcomes in Corneal Infection: Linking Adjunctive Tβ4 Treatment to Nerve Regeneration and Visual Function. Read Post »

Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice.

NMN supplementation restored hepatic NAD+ levels in alcohol-fed mice, which attenuated liver steatosis, inflammation, and oxidative stress through restoration of the Hamp iron-regulation pathway. The mechanism involves C/EBPα-mediated transcriptional control of Hamp expression, linking NAD+ metabolism to iron homeostasis and lipid metabolism. This identifies NMN as a targeted dietary therapeutic for alcohol-associated liver disease (ALD) with a well-characterized molecular pathway, offering practitioners a science-backed rationale for recommending NMN to patients with metabolic liver dysfunction.

Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice. Read Post »

Coordination-Driven Cu2+-Peptide Supramolecular Hydrogel-PCL Scaffold for Synergistic Antibacterial Activity and Osteogenic Regeneration in Infectious Bone Defects.

Researchers developed a copper-peptide hydrogel scaffold that combines antibacterial, antioxidant, and bone-regenerative properties for treating infected bone defects. The material showed >99% efficacy against resistant bacteria (MRSA, Pseudomonas), reduced oxidative stress, and promoted osteoblast differentiation and new bone formation in rat models. This demonstrates a metal-peptide coordination strategy relevant to GHK-Cu’s known copper-dependent mechanisms in tissue repair and antimicrobial activity.

Coordination-Driven Cu2+-Peptide Supramolecular Hydrogel-PCL Scaffold for Synergistic Antibacterial Activity and Osteogenic Regeneration in Infectious Bone Defects. Read Post »

Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptide Applications, Reports on Initial Formulation Work Across Multiple Peptides Including BPC-157 – Business Wire

Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptide Applications, Reports on Initial Formulation Work Across Multiple Peptides Including BPC-157  Business Wire

Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptide Applications, Reports on Initial Formulation Work Across Multiple Peptides Including BPC-157 – Business Wire Read Post »

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis – Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation – The Manila Times

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis – Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation  The Manila Times

Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis – Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation – The Manila Times Read Post »

Scroll to Top